APA (7th ed.) Citation

XM, H., MC, H., P, Y., QW, Z., ZQ, C., W, H., & QS, W. (2022). Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. Frontiers in pharmacology, 13, 896418. https://doi.org/10.3389/fphar.2022.896418

Chicago Style (17th ed.) Citation

XM, He, He MC, Yang P, Zhang QW, Chen ZQ, He W, and Wei QS. "Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years." Frontiers in Pharmacology 13 (2022): 896418. https://doi.org/10.3389/fphar.2022.896418.

MLA (9th ed.) Citation

XM, He, et al. "Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years." Frontiers in Pharmacology, vol. 13, 2022, p. 896418, https://doi.org/10.3389/fphar.2022.896418.